News AZ and Oracle team up on AI platform for clinical trials AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
News AI in drug discovery & development: News watch, October 2026 Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
News MHRA lays out its thinking on AI and medicines regulation An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
News Zealand forges obesity alliance with AI specialist Generate Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
News Biohub raises $1.8bn for its 'virtual biology' initiative Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.
News Click claims FDA okay for first-in-class schizophrenia DTx Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.